This week we had the privileged to host the @SocSurgOnc executive leadership team, president @KennethTanabeMD , president-elect @TariKingMD and CEO @pstellastar4 at IRCAD North America @AtriumHealth@wakeforestmed in Charlotte, NC. We had very insightful and productive discussions in how to advance the field of surgical oncology innovation, education, training and research through the strengthening of academic centers, societal and industry collaborations in healthcare.
Also grateful for the visit of @advocatehealth Cancer Service Line leaders: JosephWeber, Nikolaos Dallas, MD,@WesleyPapenfuss and the leadership of Dionisios Vrochides, MD, PhD, F, @BrentDMatthews & @mpdrc 🙏
A computer vision algorithm using preoperative CT scans demonstrated comparable performance to expert radiologists and surgeons in predicting SMA margin status after Whipple for pancreatic ductal adenocarcinoma. https://t.co/eW5JQixYLh
Prehabilitation improves recovery and reduces complications for patients undergoing colorectal surgery, yet generalizability and feasibility depend on program adherence and addressing patient-centered psychosocial outcomes. https://t.co/g5mvBm9v3F
In a multicenter RCT of patients undergoing pancreaticojejunostomy after pancreatoduodenectomy, double-layer polyglycolic acid felt did not reduce rates of clinically relevant postoperative pancreatic fistula. https://t.co/AXQAVemfub
#Obesity is associated with higher risk for 12 #cancer types and accounts for approximately 10% of annual new cancer cases in the US.
📄 This Review summarizes the primary biological pathways connecting obesity and cancer development.
https://t.co/mcFtYoQ8Z4
Excellent comprehensive review on #Obesity and #Cancer. A critical and evolving field with much work still ahead. Excited to contribute to advancing research in this space.
#Obesity is associated with higher risk for 12 #cancer types and accounts for approximately 10% of annual new cancer cases in the US.
📄 This Review summarizes the primary biological pathways connecting obesity and cancer development. https://t.co/L6mWf5nPUQ
Congrats to our extraordinary research fellow @ahmadassi_ for presenting multi-institutional study of Robotic Whipple With Vascular Resection at @SocSurgOnc#SSO2026 General Surgery Applicant #Match2027
Also grateful 🙏 for the collaboration with @HoggNDMD & Brian Boone and their research team for this project.
AI is reshaping cancer science by helping researchers process vast information and speed up innovation in care.
Have you listened to the latest ImmunoVerse episode featuring Dr. Drew Pardoll (@dpardol1), director of the Bloomberg Kimmel Institute for Cancer Immunotherapy at @HopkinsMedicine?
🎧 Listen now at https://t.co/W2AM4flJFl or on your favorite podcast platform!
#AI #CancerResearch #ImmunotherapyPodcast #Immunotherapy
@FDA has approved the NoVocure device to
treat locally advanced #PDAC with tumor
treating fields (TTF) based on positive OS
results from the PANOVA trial.
Great to have more options with proven
benefit in this space.
@PanCAN@OHSUKnight
https://t.co/N4eJYrRFqI
Gastric cancer is the fifth most diagnosed #cancer and the fifth leading cause of cancer-related deaths worldwide.
📌 This Review summarizes the epidemiology, pathophysiology, diagnosis, and management of #GastricCancer.
https://t.co/fAdPCeSz3a
Have you ever wondered why do large (>3cm) & Mixed Type IPMNs have a higher risk of invasive neoplasia and carcinoma?
In these @JAMASurgery & @acsJACS publications led by @amudhan_kannan for our research group we attempt to decipher the biological behavior of IPMN using NGS
The complexity of cancer, with its bewildering variety of forms, makes devising treatments difficult. But progress is being made https://t.co/XPxFpRT7yN